Dr. Susan M. Goobie, MD, FRCPC is an Assistant Professor of Anesthesiology, Peri-operative and Pain Medicine and Director of the Clinical Pharmacology and Pharmacokinetics Laboratory at Boston Children’s Hospital, Harvard Medical School. She has clinical and research interests in optimizing care for children having major surgery including craniofacial, scoliosis and neurosurgery. She has developed expert knowledge in blood conservation methods, coagulation disorders and pharmacological research. She investigated the pharmacodynamic and pharmacokinetic profile of tranexamic acid in a randomized double-blinded trial and showed that tranexamic acid significantly reduced blood loss and blood transfusion requirements in craniofacial surgery. This has become standard of care internationally for this patient population. Furthermore, in a novel pharmacokinetic study, she recommended the best dose to maximize efficacy and reduce potential side effects in children having craniofacial surgery. Currently she is studying the efficacy and safety profile of antifibrinolytics for craniosynostosis, idiopathic scoliosis surgery and pediatric trauma. Her research is innovative, as it will shed new insights and provide clinical guidelines into the mechanism of action, optimum dose, efficacy, and safety of antifibrinolytic use for pediatric non-cardiac surgery.
Dr. Goobie shares her clinical and research expertise in the field of pediatric blood management by regularly presenting this work and speaking at international meetings and publishing original research, reviews, chapters and editorial views pertaining to blood conservation techniques and antifibrinolytic use in pediatric surgery. She is a regular reviewer for major anesthesia journals such as Anesthesia and Analgesia, and Pediatric Anesthesia. She is president-elect of the International Pediatric Craniofacial Collaborative Registry and Chair of the Scientific Committee of the Society for the Advancement of Blood Management. She is an internationally recognized expert, co-investigator and consultant on several large multicentre trials in the area of Pediatric Patient Blood Management. Dr. Goobie is from Newfoundland, Canada and lives in Boston with her husband and three children. In her spare time she enjoys cycling, running, skiing and snowboarding.
Richard J. Ing MBBCh, FCA (SA) is a graduate of The University of the Witwatersrand Medical School, Johannesburg South Africa where he completed Specialist Anesthesiology training in 1995. He has practiced anesthesia in Johannesburg and Cape Town South Africa, the United States in Durham North Carolina and since 2011 he has been practicing anesthesia in Denver at Children’s Hospital Colorado. His clinical interests are in the care of pediatric and adult congenital heart disease patients for anesthesia. He enjoys teaching and clinical research. His interests include the anesthetic care of patients with cardiomyopathy, pulmonary hypertension, arrhythmias and single ventricle anatomy. Dr Ing is currently an Associate Professor of Anesthesiology in the School of Medicine at the University of Colorado.
Dr. Stricker’s passion for improving the care of infants and children with craniofacial abnormalities has been the unifying force behind his career. His research and education activities have been centered on two populations: infants undergoing craniofacial reconstruction surgery and children with difficult airways. In the field of pediatric airway management, Dr. Stricker has authored several chapters as well as numerous editorials and peer-reviewed publications. He has lectured and served as a workshop instructor at national and international meetings; he currently serves as the organizing director of the difficult airway workshop at the Society for Pediatric Anesthesia annual meeting. Dr. Stricker’s primary research focus is clinical outcomes research using observational databases in children undergoing craniofacial reconstruction surgery. In one of Dr. Stricker’s initial studies, he showed how blood loss replacement strategy using donor-matched FFP and packed red blood cells reduced blood donor exposures and prevented coagulopathy. In a subsequent work, he demonstrated how implementation of postoperative transfusion thresholds significantly reduced perioperative transfusion.
Bernhard Ziegler finished his studies at the Leopold Franzens University at Innsbruck (Austria) in 1991 where he received his MD. He subsequently worked as a General Practitioner and an Anaesthetist at the Paracelsus Medical University in Salzburg Austria where he also held the position of Co-Chairman of the Department of Pediatric Anaesthesia for 10 years.
During the early 2000’s, Bernhard specialized in perioperative haemostasis and since then he became a member of The Society of Thrombosis and Haemostasis Research GTH, The Austrian Working Group of Perioperative Haemostasis and also The Austrian Working Group of Pediatric Anaesthesia.
Bernhard is currently working as a Senior Pediatric Anesthesiologist at the Department of Pediatric Anaesthesia at Zurich University Children's Hospital where on a daily basis he deals with cases of great blood loss. The University Children`s Hospital Zurich is also a center for management and education for the difficult airway. Bernard has attended more than 4000 emergency missions with the Ambulance Team and the Rescue Helicopter Team.
